Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,371,603 papers from all fields of science
Search
Sign In
Create Free Account
Salinispora
Known as:
MAR 1
, Salinospora
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Use of genome-scale models to get new insights into the marine actinomycete genus Salinispora
C. Contador
,
V. Rodríguez
,
B. Andrews
,
J. Asenjo
BMC Systems Biology
2019
Corpus ID: 58558437
BackgroundThere is little published regarding metabolism of Salinispora species. In continuation with efforts performed towards…
Expand
2018
2018
Genome-scale reconstruction of Salinispora tropica metabolism; Microbial engineering and its applications in secondary metabolite production
B. Andrews
,
V. D. Saucedo
,
J. Asenjo
,
C. Contador
2018
Corpus ID: 90467815
Bacteria within the order Actinomycetales are a well-known source of natural products such as antibiotics and anticancer agents…
Expand
2014
2014
CRISPR-Cas systems in the marine actinomycete Salinispora: linkages with phage defense, microdiversity and biogeography
Matthias Wietz
,
Natalie Millán-Aguiñaga
,
P. Jensen
BMC Genomics
2014
Corpus ID: 2053403
BackgroundProkaryotic CRISPR-Cas systems confer resistance to viral infection and thus mediate bacteria-phage interactions…
Expand
2014
2014
CRISPR-Cas systems in the marine actinomycete Salinispora: linkages with phage defense, microdiversity and biogeography
Matthias Wietz
,
Natalie Millán-Aguiñaga
,
P. Jensen
BMC Genomics
2014
Corpus ID: 255786554
Prokaryotic CRISPR-Cas systems confer resistance to viral infection and thus mediate bacteria-phage interactions. However, the…
Expand
2013
2013
Biodiversity of Actinomycetes Associated with Caribbean Sponges and Their Potential for Natural Product Discovery
Jan Vicente
,
A. Stewart
,
B. Song
,
R. Hill
,
Jeffrey L. C. Wright
Marine Biotechnology
2013
Corpus ID: 16574946
Marine actinomycetes provide a rich source of structurally unique and bioactive secondary metabolites. Numerous genera of marine…
Expand
2013
2013
[Isolation of actinobacteria with antibiotic associated with soft coral Nephthea sp].
Liang Ma
,
Wenjun Zhang
,
+4 authors
Changsheng Zhang
Wei sheng wu xue bao = Acta microbiologica Sinica
2013
Corpus ID: 32227868
OBJECTIVE The present study aims to isolate and identify actinobacteria associated with the soft coral Nephthea sp., and to…
Expand
2012
2012
Diversity and distribution of the marine actinomycete genus salinispora and evolution of secondary metabolite pathways
Kelle C. Freel
2012
Corpus ID: 81971564
Bacteria are found in every environment on the planet, play roles in many important global cycles, and are responsible for many…
Expand
2011
2011
Diversity and distribution of the bioactive actinobacterial genus Salinispora from sponges along the Great Barrier Reef
M. Vidgen
,
J. Hooper
,
J. Fuerst
Antonie van Leeuwenhoek
2011
Corpus ID: 254224178
Isolates from the marine actinobacterial genus Salinispora were cultured from marine sponges collected from along the length of…
Expand
2010
2010
A preliminary investigation on the growth requirement for monovalent cations, divalent cations and medium ionic strength of marine actinomycete Salinispora
Ginger Tsueng
,
K. S. Lam
Applied Microbiology and Biotechnology
2010
Corpus ID: 26775348
In this paper, we report that three species of Salinispora, S. arenicola, S. tropica, and S. pacifica, require magnesium and…
Expand
2005
2005
The Novel, Orally Active Proteasome Inhibitor, NPI-0052, Induces Apoptosis in Leukemia Lymphoma Cell Lines and Patient Specimens.
Claudia P. Miller
,
Kechen Ban
,
+4 authors
J. Chandra
2005
Corpus ID: 221204285
NPI-0052 is the second proteasome inhibitor with potential for clinical use since the FDA approval of bortezomib. NPI-0052 is a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE